Humanised Igg2 Monoclonal Antibody Against Interleukin-6

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

9 Countries

Phase III

Phase III: 2

Oversight events:

1 serious breach across 1 trial

View oversight register →

Sponsors using this IMP

F. Hoffmann-La Roche AG 2

All trials

2 total

A STUDY TO INVESTIGATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7200220 ADMINISTERED INTRAVITREALLY IN PATIENTS WIT… Ended

2022-501794-39-00 Phase III 6 countries F. Hoffmann-La Roche AG
A Study to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients wit… Ended

2022-501793-19-00 Phase III 5 countries F. Hoffmann-La Roche AG

Showing 1–2 of 2 trials

← All drugs A–Z